Evidence map›Paper›PMID 10759785›Full record

ArticleClinical and experimental immunology2000

Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen.

B T Kurien, J Newland, C Paczkowski, K L Moore, R H Scofield

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Purification of Tryptic Digests on Polyvinylidene Difluoride Membrane.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  17. Haematological manifestations of lupus.Lupus science & medicine · 2015
    Review
  18. Western blotting: an introduction.Methods in molecular biology (Clifton, N.J.) · 2015
    Review
  19. Western blotting of high and low molecular weight proteins using heat.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

B T KurienArthritis/Immunology and Cardiovascular Biology Programs, Oklahoma Medical Research Foundation, and Department of Medicine, University of Oklahoma Health Science Center, Veterans Affairs Medical Center, Oklahoma City, OK, USA.
J Newland
C Paczkowski
K L Moore
R H Scofield
Oklahoma Medical Research Foundation · USUniversity of Oklahoma · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SLE is associated with the production of autoantibodies to self-constituents. In particular, certain ribonucleoprotein particles are targeted. Despite the multitude of autoantibodies produced and the remarkable concentrations of these antibodies in the sera of SLE patients, there have been little data that the autoantibodies found in SLE are involved in the pathogenesis of disease or its manifestations. The present work demonstrates that anti-Ro (or SSA) is associated with granulocytopenia, binds the surface of granulocytes and fixes complement to this membrane surface. Binding is a property of anti-Ro Fab fragments and can be inhibited by 60-kD Ro. However, the antigen bound on the surface of granulocytes is a 64 000 mol. wt protein that is a novel autoantigen in SLE. As suggested by inhibition studies, sequence identity between 60-kD Ro and eight tandem repeats in the 64-kD antigen may be responsible for the observed serologic cross-reactivity. These data imply that anti-Ro antibodies that also bind the 64-kD protein mediate neutropenia in patients with SLE.

Indexed as

RNA, Small CytoplasmicAdultAntibodies, AntinuclearAntigens, SurfaceAutoantigensBinding Sites, AntibodyCross ReactionsFemaleFlow CytometryGranulocytesHumansLupus Erythematosus, SystemicMaleMass SpectrometryMembrane GlycoproteinsNeutropeniaAntibodies, AntinuclearAntigens, SurfaceAutoantigensMembrane GlycoproteinsPeptide FragmentsRibonucleoproteinsRNA, Small CytoplasmicRO60 protein, humanSS-A antibodiesSS-A Antigen

Identifiers

PMID10759785
PMCPMC1905619
OpenAlexW1979016248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.